Inhibition of HIF-1α and silencing of VEGFA diminished cell viability and pro-angiogenic properties, indicating that HIF-1α/VEGFA-induced angiogenesis following interventional RFA may significantly contribute to the rapid growth of residual HCC cells (Kong et al., 2012a). The gene discussed is HIF1A; the disease is hepatocellular carcinoma.